#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=Study suggests ' sleeping sickness ' parasite mutated to evade immune system defences
1-1	0-5	Study	abstract	new	coref	5-1[23_0]
1-2	6-14	suggests	_	_	_	_
1-3	15-16	'	person[4]	new[4]	coref	4-13[17_4]
1-4	17-25	sleeping	abstract|abstract[3]|person[4]	new|new[3]|new[4]	coref	4-19[18_3]
1-5	26-34	sickness	abstract[3]|person[4]	new[3]|new[4]	_	_
1-6	35-36	'	person[4]	new[4]	_	_
1-7	37-45	parasite	person[4]	new[4]	_	_
1-8	46-53	mutated	person[4]	new[4]	_	_
1-9	54-56	to	person[4]	new[4]	_	_
1-10	57-62	evade	person[4]	new[4]	_	_
1-11	63-69	immune	person[4]|abstract[5]|abstract[6]	new[4]|new[5]|new[6]	coref	4-25[21_5]
1-12	70-76	system	person[4]|abstract[5]|abstract[6]	new[4]|new[5]|new[6]	_	_
1-13	77-85	defences	person[4]|abstract[6]	new[4]|new[6]	_	_

#Text=Wednesday , September 1 , 2010
2-1	86-95	Wednesday	time	new	appos	2-3[8_0]
2-2	96-97	,	_	_	_	_
2-3	98-107	September	time[8]	giv[8]	_	_
2-4	108-109	1	time[8]	giv[8]	_	_
2-5	110-111	,	time[8]	giv[8]	_	_
2-6	112-116	2010	time[8]|time	giv[8]|new	_	_

#Text=File photo of trypanosoma brucei
3-1	117-121	File	object[10]	new[10]	_	_
3-2	122-127	photo	object[10]	new[10]	_	_
3-3	128-130	of	object[10]	new[10]	_	_
3-4	131-142	trypanosoma	object[10]|abstract[11]	new[10]|new[11]	coref	15-24[88_11]
3-5	143-149	brucei	object[10]|abstract[11]	new[10]|new[11]	_	_

#Text=Research teams from the universities of Georgia and Glasgow discovered the mechanism the Trypanosome parasite evolved for " sleeping sickness " disease to circumvent the human immune system .
4-1	150-158	Research	organization[12]	new[12]	_	_
4-2	159-164	teams	organization[12]	new[12]	_	_
4-3	165-169	from	organization[12]	new[12]	_	_
4-4	170-173	the	organization[12]|organization[13]	new[12]|new[13]	_	_
4-5	174-186	universities	organization[12]|organization[13]	new[12]|new[13]	_	_
4-6	187-189	of	organization[12]|organization[13]	new[12]|new[13]	_	_
4-7	190-197	Georgia	organization[12]|organization[13]|place	new[12]|new[13]|new	_	_
4-8	198-201	and	organization[12]|organization[13]	new[12]|new[13]	_	_
4-9	202-209	Glasgow	organization[12]|organization[13]	new[12]|new[13]	_	_
4-10	210-220	discovered	_	_	_	_
4-11	221-224	the	abstract[15]	new[15]	_	_
4-12	225-234	mechanism	abstract[15]	new[15]	_	_
4-13	235-238	the	abstract[15]|person[17]	new[15]|giv[17]	coref	5-11[26_17]
4-14	239-250	Trypanosome	abstract[15]|abstract|person[17]	new[15]|new|giv[17]	coref	17-16
4-15	251-259	parasite	abstract[15]|person[17]	new[15]|giv[17]	_	_
4-16	260-267	evolved	abstract[15]	new[15]	_	_
4-17	268-271	for	abstract[15]	new[15]	_	_
4-18	272-273	"	abstract[15]|abstract[19]	new[15]|new[19]	coref	5-9[25_19]
4-19	274-282	sleeping	abstract[15]|abstract[18]|abstract[19]	new[15]|giv[18]|new[19]	coref	8-5[35_18]
4-20	283-291	sickness	abstract[15]|abstract[18]|abstract[19]	new[15]|giv[18]|new[19]	_	_
4-21	292-293	"	abstract[15]|abstract[19]	new[15]|new[19]	_	_
4-22	294-301	disease	abstract[15]|abstract[19]	new[15]|new[19]	_	_
4-23	302-304	to	abstract[15]	new[15]	_	_
4-24	305-315	circumvent	abstract[15]	new[15]	_	_
4-25	316-319	the	abstract[15]|abstract[21]	new[15]|giv[21]	coref	13-6[74_21]
4-26	320-325	human	abstract[15]|abstract[21]	new[15]|giv[21]	_	_
4-27	326-332	immune	abstract[15]|organization|abstract[21]	new[15]|new|giv[21]	coref	13-8
4-28	333-339	system	abstract[15]|abstract[21]	new[15]|giv[21]	_	_
4-29	340-341	.	_	_	_	_

#Text=Their study follows a recent African outbreak of the disease this parasite causes .
5-1	342-347	Their	person|abstract[23]	acc|giv[23]	coref	21-1[120_23]
5-2	348-353	study	abstract[23]	giv[23]	_	_
5-3	354-361	follows	_	_	_	_
5-4	362-363	a	event[24]	new[24]	_	_
5-5	364-370	recent	event[24]	new[24]	_	_
5-6	371-378	African	event[24]	new[24]	_	_
5-7	379-387	outbreak	event[24]	new[24]	_	_
5-8	388-390	of	event[24]	new[24]	_	_
5-9	391-394	the	event[24]|abstract[25]	new[24]|giv[25]	coref	25-41[171_25]
5-10	395-402	disease	event[24]|abstract[25]	new[24]|giv[25]	_	_
5-11	403-407	this	event[24]|abstract[25]|person[26]	new[24]|giv[25]|giv[26]	coref	12-15[66_26]
5-12	408-416	parasite	event[24]|abstract[25]|person[26]	new[24]|giv[25]|giv[26]	_	_
5-13	417-423	causes	event[24]|abstract[25]	new[24]|giv[25]	_	_
5-14	424-425	.	_	_	_	_

#Text=The discovery is expected to help develop a cure preventing future deaths .
6-1	426-429	The	event[27]	new[27]	_	_
6-2	430-439	discovery	event[27]	new[27]	_	_
6-3	440-442	is	_	_	_	_
6-4	443-451	expected	_	_	_	_
6-5	452-454	to	_	_	_	_
6-6	455-459	help	_	_	_	_
6-7	460-467	develop	_	_	_	_
6-8	468-469	a	event[28]	new[28]	_	_
6-9	470-474	cure	event[28]	new[28]	_	_
6-10	475-485	preventing	event[28]	new[28]	_	_
6-11	486-492	future	event[28]|event[29]	new[28]|new[29]	coref	8-24[43_29]
6-12	493-499	deaths	event[28]|event[29]	new[28]|new[29]	_	_
6-13	500-501	.	_	_	_	_

#Text=A tsetse fly , generally responsible for the spread of the condition .
7-1	502-503	A	animal[31]	new[31]	_	_
7-2	504-510	tsetse	animal|animal[31]	new|new[31]	coref	9-6
7-3	511-514	fly	animal[31]	new[31]	_	_
7-4	515-516	,	animal[31]	new[31]	_	_
7-5	517-526	generally	animal[31]	new[31]	_	_
7-6	527-538	responsible	animal[31]	new[31]	_	_
7-7	539-542	for	_	_	_	_
7-8	543-546	the	event[32]	new[32]	_	_
7-9	547-553	spread	event[32]	new[32]	_	_
7-10	554-556	of	event[32]	new[32]	_	_
7-11	557-560	the	event[32]|abstract[33]	new[32]|new[33]	_	_
7-12	561-570	condition	event[32]|abstract[33]	new[32]|new[33]	_	_
7-13	571-572	.	_	_	_	_

#Text=The 1998 – 2001 sleeping sickness epidemics in South Sudan , Angola , Democratic Republic of Congo , and Uganda caused tens of thousands of deaths .
8-1	573-576	The	event[36]	new[36]	coref	10-6[49_36]
8-2	577-581	1998	event[36]	new[36]	_	_
8-3	582-583	–	event[36]	new[36]	_	_
8-4	584-588	2001	time|event[36]	new|new[36]	_	_
8-5	589-597	sleeping	abstract[35]|event[36]	giv[35]|new[36]	_	_
8-6	598-606	sickness	abstract[35]|event[36]	giv[35]|new[36]	_	_
8-7	607-616	epidemics	event[36]	new[36]	_	_
8-8	617-619	in	event[36]	new[36]	_	_
8-9	620-625	South	event[36]|place[37]	new[36]|new[37]	_	_
8-10	626-631	Sudan	event[36]|place[37]	new[36]|new[37]	_	_
8-11	632-633	,	event[36]	new[36]	_	_
8-12	634-640	Angola	event[36]|place	new[36]|new	_	_
8-13	641-642	,	event[36]	new[36]	_	_
8-14	643-653	Democratic	event[36]|place[39]	new[36]|new[39]	_	_
8-15	654-662	Republic	event[36]|place[39]	new[36]|new[39]	_	_
8-16	663-665	of	event[36]|place[39]	new[36]|new[39]	_	_
8-17	666-671	Congo	event[36]|place[39]|place	new[36]|new[39]|new	_	_
8-18	672-673	,	event[36]	new[36]	_	_
8-19	674-677	and	event[36]	new[36]	_	_
8-20	678-684	Uganda	event[36]|place	new[36]|new	ana	10-1
8-21	685-691	caused	_	_	_	_
8-22	692-696	tens	abstract[42]	new[42]	_	_
8-23	697-699	of	abstract[42]	new[42]	_	_
8-24	700-709	thousands	abstract[42]|event[43]	new[42]|giv[43]	coref	20-17[118_43]
8-25	710-712	of	abstract[42]|event[43]	new[42]|giv[43]	_	_
8-26	713-719	deaths	abstract[42]|event[43]	new[42]|giv[43]	_	_
8-27	720-721	.	_	_	_	_

#Text=The parasites are spread by tsetse flies .
9-1	722-725	The	animal[44]	new[44]	coref	14-7[79_44]
9-2	726-735	parasites	animal[44]	new[44]	_	_
9-3	736-739	are	_	_	_	_
9-4	740-746	spread	_	_	_	_
9-5	747-749	by	_	_	_	_
9-6	750-756	tsetse	animal|animal[46]	giv|new[46]	_	_
9-7	757-762	flies	animal[46]	new[46]	_	_
9-8	763-764	.	_	_	_	_

#Text=It is considered one of the worst epidemics in the last five decades .
10-1	765-767	It	place	giv	_	_
10-2	768-770	is	_	_	_	_
10-3	771-781	considered	_	_	_	_
10-4	782-785	one	person[48]	new[48]	_	_
10-5	786-788	of	person[48]	new[48]	_	_
10-6	789-792	the	person[48]|event[49]	new[48]|giv[49]	_	_
10-7	793-798	worst	person[48]|event[49]	new[48]|giv[49]	_	_
10-8	799-808	epidemics	person[48]|event[49]	new[48]|giv[49]	_	_
10-9	809-811	in	person[48]|event[49]	new[48]|giv[49]	_	_
10-10	812-815	the	person[48]|event[49]|time[50]	new[48]|giv[49]|new[50]	_	_
10-11	816-820	last	person[48]|event[49]|time[50]	new[48]|giv[49]|new[50]	_	_
10-12	821-825	five	person[48]|event[49]|time[50]	new[48]|giv[49]|new[50]	_	_
10-13	826-833	decades	person[48]|event[49]|time[50]	new[48]|giv[49]|new[50]	_	_
10-14	834-835	.	_	_	_	_

#Text=As WHO reported , subsequent recent introduction of population screening in rural areas and distribution of more effective drugs had potentially reduced the number of death incidents .
11-1	836-838	As	_	_	_	_
11-2	839-842	WHO	organization	new	_	_
11-3	843-851	reported	_	_	_	_
11-4	852-853	,	_	_	_	_
11-5	854-864	subsequent	event[52]	new[52]	_	_
11-6	865-871	recent	event[52]	new[52]	_	_
11-7	872-884	introduction	event[52]	new[52]	_	_
11-8	885-887	of	event[52]	new[52]	_	_
11-9	888-898	population	event[52]|abstract|abstract[54]	new[52]|new|new[54]	_	_
11-10	899-908	screening	event[52]|abstract[54]	new[52]|new[54]	_	_
11-11	909-911	in	event[52]|abstract[54]	new[52]|new[54]	_	_
11-12	912-917	rural	event[52]|abstract[54]|place[55]	new[52]|new[54]|new[55]	_	_
11-13	918-923	areas	event[52]|abstract[54]|place[55]	new[52]|new[54]|new[55]	_	_
11-14	924-927	and	_	_	_	_
11-15	928-940	distribution	abstract[56]	new[56]	_	_
11-16	941-943	of	abstract[56]	new[56]	_	_
11-17	944-948	more	abstract[56]|substance[57]	new[56]|new[57]	_	_
11-18	949-958	effective	abstract[56]|substance[57]	new[56]|new[57]	_	_
11-19	959-964	drugs	abstract[56]|substance[57]	new[56]|new[57]	_	_
11-20	965-968	had	_	_	_	_
11-21	969-980	potentially	_	_	_	_
11-22	981-988	reduced	_	_	_	_
11-23	989-992	the	abstract[58]	new[58]	_	_
11-24	993-999	number	abstract[58]	new[58]	_	_
11-25	1000-1002	of	abstract[58]	new[58]	_	_
11-26	1003-1008	death	abstract[58]|event|event[60]	new[58]|new|new[60]	coref	14-14[81_0]
11-27	1009-1018	incidents	abstract[58]|event[60]	new[58]|new[60]	_	_
11-28	1019-1020	.	_	_	_	_

#Text=However , the main effect of these measures being a decrease in spreading of the parasite and not in decrease of the death rate , the researchers decided to tackle the puzzle .
12-1	1021-1028	However	_	_	_	_
12-2	1029-1030	,	_	_	_	_
12-3	1031-1034	the	event[61]	new[61]	coref	12-10[63_61]
12-4	1035-1039	main	event[61]	new[61]	_	_
12-5	1040-1046	effect	event[61]	new[61]	_	_
12-6	1047-1049	of	event[61]	new[61]	_	_
12-7	1050-1055	these	event[61]|abstract[62]	new[61]|new[62]	_	_
12-8	1056-1064	measures	event[61]|abstract[62]	new[61]|new[62]	_	_
12-9	1065-1070	being	_	_	_	_
12-10	1071-1072	a	event[63]|event[64]	giv[63]|giv[64]	coref	12-10[64_63]
12-11	1073-1081	decrease	event[63]|event[64]	giv[63]|giv[64]	_	_
12-12	1082-1084	in	event[63]|event[64]	giv[63]|giv[64]	_	_
12-13	1085-1094	spreading	event[63]|event[64]|event[65]	giv[63]|giv[64]|new[65]	_	_
12-14	1095-1097	of	event[63]|event[64]|event[65]	giv[63]|giv[64]|new[65]	_	_
12-15	1098-1101	the	event[63]|event[64]|event[65]|person[66]	giv[63]|giv[64]|new[65]|giv[66]	coref	15-5[0_66]
12-16	1102-1110	parasite	event[63]|event[64]|event[65]|person[66]	giv[63]|giv[64]|new[65]|giv[66]	_	_
12-17	1111-1114	and	event[64]	giv[64]	_	_
12-18	1115-1118	not	event[64]	giv[64]	_	_
12-19	1119-1121	in	event[64]	giv[64]	_	_
12-20	1122-1130	decrease	event[64]|event[67]	giv[64]|new[67]	coref	22-16[131_67]
12-21	1131-1133	of	event[64]|event[67]	giv[64]|new[67]	_	_
12-22	1134-1137	the	event[64]|event[67]|abstract[68]	giv[64]|new[67]|new[68]	_	_
12-23	1138-1143	death	event[64]|event[67]|abstract[68]	giv[64]|new[67]|new[68]	_	_
12-24	1144-1148	rate	event[64]|event[67]|abstract[68]	giv[64]|new[67]|new[68]	_	_
12-25	1149-1150	,	_	_	_	_
12-26	1151-1154	the	person[69]	new[69]	coref	17-1[0_69]
12-27	1155-1166	researchers	person[69]	new[69]	_	_
12-28	1167-1174	decided	_	_	_	_
12-29	1175-1177	to	_	_	_	_
12-30	1178-1184	tackle	_	_	_	_
12-31	1185-1188	the	abstract[70]	new[70]	_	_
12-32	1189-1195	puzzle	abstract[70]	new[70]	_	_
12-33	1196-1197	.	_	_	_	_

#Text=The scientists studied the molecules the human immune system activates in response to the attack .
13-1	1198-1201	The	person[71]	new[71]	ana	14-1[0_71]
13-2	1202-1212	scientists	person[71]	new[71]	_	_
13-3	1213-1220	studied	_	_	_	_
13-4	1221-1224	the	substance[72]	new[72]	_	_
13-5	1225-1234	molecules	substance[72]	new[72]	_	_
13-6	1235-1238	the	substance[72]|abstract[74]	new[72]|giv[74]	coref	18-5[102_74]
13-7	1239-1244	human	substance[72]|abstract[74]	new[72]|giv[74]	_	_
13-8	1245-1251	immune	substance[72]|organization|abstract[74]	new[72]|giv|giv[74]	coref	23-26
13-9	1252-1258	system	substance[72]|abstract[74]	new[72]|giv[74]	_	_
13-10	1259-1268	activates	substance[72]	new[72]	_	_
13-11	1269-1271	in	substance[72]	new[72]	_	_
13-12	1272-1280	response	substance[72]|abstract[75]	new[72]|new[75]	_	_
13-13	1281-1283	to	substance[72]|abstract[75]	new[72]|new[75]	_	_
13-14	1284-1287	the	substance[72]|abstract[75]|event[76]	new[72]|new[75]|new[76]	_	_
13-15	1288-1294	attack	substance[72]|abstract[75]|event[76]	new[72]|new[75]|new[76]	_	_
13-16	1295-1296	.	_	_	_	_

#Text=They were looking for the way the parasites inhibit it and lead to the death of the victim .
14-1	1297-1301	They	person	giv	_	_
14-2	1302-1306	were	_	_	_	_
14-3	1307-1314	looking	_	_	_	_
14-4	1315-1318	for	_	_	_	_
14-5	1319-1322	the	abstract[78]	new[78]	ana	14-10[0_78]
14-6	1323-1326	way	abstract[78]	new[78]	_	_
14-7	1327-1330	the	abstract[78]|animal[79]	new[78]|giv[79]	coref	18-14[103_79]
14-8	1331-1340	parasites	abstract[78]|animal[79]	new[78]|giv[79]	_	_
14-9	1341-1348	inhibit	abstract[78]	new[78]	_	_
14-10	1349-1351	it	abstract[78]|abstract	new[78]|giv	_	_
14-11	1352-1355	and	abstract[78]	new[78]	_	_
14-12	1356-1360	lead	abstract[78]	new[78]	_	_
14-13	1361-1363	to	_	_	_	_
14-14	1364-1367	the	event[81]	giv[81]	_	_
14-15	1368-1373	death	event[81]	giv[81]	_	_
14-16	1374-1376	of	event[81]	giv[81]	_	_
14-17	1377-1380	the	event[81]|person[82]	giv[81]|new[82]	_	_
14-18	1381-1387	victim	event[81]|person[82]	giv[81]|new[82]	_	_
14-19	1388-1389	.	_	_	_	_

#Text=Of the several known parasite species , the two that can infect humans were chosen to study , called Trypanosoma brucei gambiense and Trypanosoma brucei rhodensiense .
15-1	1390-1392	Of	_	_	_	_
15-2	1393-1396	the	animal[84]	new[84]	coref	22-11[130_84]
15-3	1397-1404	several	animal[84]	new[84]	_	_
15-4	1405-1410	known	animal[84]	new[84]	_	_
15-5	1411-1419	parasite	person|animal[84]	giv|new[84]	coref	21-15[124_0]
15-6	1420-1427	species	animal[84]	new[84]	_	_
15-7	1428-1429	,	_	_	_	_
15-8	1430-1433	the	abstract[85]	new[85]	_	_
15-9	1434-1437	two	abstract[85]	new[85]	_	_
15-10	1438-1442	that	abstract[85]	new[85]	_	_
15-11	1443-1446	can	abstract[85]	new[85]	_	_
15-12	1447-1453	infect	abstract[85]	new[85]	_	_
15-13	1454-1460	humans	abstract[85]|animal	new[85]|new	coref	18-6[101_0]
15-14	1461-1465	were	_	_	_	_
15-15	1466-1472	chosen	_	_	_	_
15-16	1473-1475	to	_	_	_	_
15-17	1476-1481	study	_	_	_	_
15-18	1482-1483	,	_	_	_	_
15-19	1484-1490	called	_	_	_	_
15-20	1491-1502	Trypanosoma	person[87]	new[87]	_	_
15-21	1503-1509	brucei	person[87]	new[87]	_	_
15-22	1510-1519	gambiense	person[87]	new[87]	_	_
15-23	1520-1523	and	_	_	_	_
15-24	1524-1535	Trypanosoma	abstract[88]	giv[88]	coref	17-5[0_88]
15-25	1536-1542	brucei	abstract[88]	giv[88]	_	_
15-26	1543-1555	rhodensiense	abstract[88]	giv[88]	_	_
15-27	1556-1557	.	_	_	_	_

#Text=Several others also exist , but they affect only animals .
16-1	1558-1565	Several	person[89]	new[89]	ana	16-7[0_89]
16-2	1566-1572	others	person[89]	new[89]	_	_
16-3	1573-1577	also	_	_	_	_
16-4	1578-1583	exist	_	_	_	_
16-5	1584-1585	,	_	_	_	_
16-6	1586-1589	but	_	_	_	_
16-7	1590-1594	they	person	giv	_	_
16-8	1595-1601	affect	_	_	_	_
16-9	1602-1606	only	animal[91]	new[91]	_	_
16-10	1607-1614	animals	animal[91]	new[91]	_	_
16-11	1615-1616	.	_	_	_	_

#Text=Researchers knew that the Trypanosoma attacks typically are repelled by an HDL , more specifically trypanosome lytic factor-1 ( TLF-1 ) .
17-1	1617-1628	Researchers	person	giv	_	_
17-2	1629-1633	knew	_	_	_	_
17-3	1634-1638	that	_	_	_	_
17-4	1639-1642	the	event[94]	new[94]	_	_
17-5	1643-1654	Trypanosoma	abstract|event[94]	giv|new[94]	_	_
17-6	1655-1662	attacks	event[94]	new[94]	_	_
17-7	1663-1672	typically	_	_	_	_
17-8	1673-1676	are	_	_	_	_
17-9	1677-1685	repelled	_	_	_	_
17-10	1686-1688	by	_	_	_	_
17-11	1689-1691	an	abstract[95]	new[95]	appos	17-14[98_95]
17-12	1692-1695	HDL	abstract[95]	new[95]	_	_
17-13	1696-1697	,	_	_	_	_
17-14	1698-1702	more	abstract[98]	giv[98]	appos	17-20[0_98]
17-15	1703-1715	specifically	abstract[98]	giv[98]	_	_
17-16	1716-1727	trypanosome	abstract|abstract[98]	giv|giv[98]	_	_
17-17	1728-1733	lytic	abstract|abstract[98]	new|giv[98]	_	_
17-18	1734-1742	factor-1	abstract[98]	giv[98]	_	_
17-19	1743-1744	(	_	_	_	_
17-20	1745-1750	TLF-1	abstract	giv	ana	18-1
17-21	1751-1752	)	_	_	_	_
17-22	1753-1754	.	_	_	_	_

#Text=It is generated in the humans ' immune system and is toxic to the parasites but not to humans .
18-1	1755-1757	It	abstract	giv	coref	22-6
18-2	1758-1760	is	_	_	_	_
18-3	1761-1770	generated	_	_	_	_
18-4	1771-1773	in	_	_	_	_
18-5	1774-1777	the	abstract[102]	giv[102]	ana	19-1[0_102]
18-6	1778-1784	humans	animal[101]|abstract[102]	giv[101]|giv[102]	coref	18-19[0_101]
18-7	1785-1786	'	animal[101]|abstract[102]	giv[101]|giv[102]	_	_
18-8	1787-1793	immune	abstract[102]	giv[102]	_	_
18-9	1794-1800	system	abstract[102]	giv[102]	_	_
18-10	1801-1804	and	_	_	_	_
18-11	1805-1807	is	_	_	_	_
18-12	1808-1813	toxic	_	_	_	_
18-13	1814-1816	to	_	_	_	_
18-14	1817-1820	the	animal[103]	giv[103]	coref	19-7[107_103]
18-15	1821-1830	parasites	animal[103]	giv[103]	_	_
18-16	1831-1834	but	_	_	_	_
18-17	1835-1838	not	_	_	_	_
18-18	1839-1841	to	_	_	_	_
18-19	1842-1848	humans	animal	giv	coref	24-30
18-20	1849-1850	.	_	_	_	_

#Text=It was known that one of the parasites , T. b. rhodensiense , has evolved an inhibitor of the toxic chemical , called Serum Resistance Associated ( SRA ) protein .
19-1	1851-1853	It	abstract	giv	coref	23-24[141_0]
19-2	1854-1857	was	_	_	_	_
19-3	1858-1863	known	_	_	_	_
19-4	1864-1868	that	_	_	_	_
19-5	1869-1872	one	person[106]	new[106]	coref	20-2[115_106]
19-6	1873-1875	of	person[106]	new[106]	_	_
19-7	1876-1879	the	person[106]|animal[107]	new[106]|giv[107]	coref	26-18[177_107]
19-8	1880-1889	parasites	person[106]|animal[107]	new[106]|giv[107]	_	_
19-9	1890-1891	,	_	_	_	_
19-10	1892-1894	T.	animal[108]	new[108]	coref	25-2[162_108]
19-11	1895-1897	b.	animal[108]	new[108]	_	_
19-12	1898-1910	rhodensiense	_	_	_	_
19-13	1911-1912	,	_	_	_	_
19-14	1913-1916	has	_	_	_	_
19-15	1917-1924	evolved	_	_	_	_
19-16	1925-1927	an	substance[109]	new[109]	_	_
19-17	1928-1937	inhibitor	substance[109]	new[109]	_	_
19-18	1938-1940	of	substance[109]	new[109]	_	_
19-19	1941-1944	the	substance[109]|substance[110]	new[109]|new[110]	_	_
19-20	1945-1950	toxic	substance[109]|substance[110]	new[109]|new[110]	_	_
19-21	1951-1959	chemical	substance[109]|substance[110]	new[109]|new[110]	_	_
19-22	1960-1961	,	substance[109]|substance[110]	new[109]|new[110]	_	_
19-23	1962-1968	called	substance[109]|substance[110]	new[109]|new[110]	_	_
19-24	1969-1974	Serum	substance[109]|substance[110]|substance|organization[112]|substance[114]	new[109]|new[110]|new|new[112]|new[114]	coref	21-17[126_114]
19-25	1975-1985	Resistance	substance[109]|substance[110]|organization[112]|substance[114]	new[109]|new[110]|new[112]|new[114]	_	_
19-26	1986-1996	Associated	substance[109]|substance[110]|substance[114]	new[109]|new[110]|new[114]	_	_
19-27	1997-1998	(	substance[109]|substance[110]|substance[114]	new[109]|new[110]|new[114]	_	_
19-28	1999-2002	SRA	substance[109]|substance[110]|abstract|substance[114]	new[109]|new[110]|new|new[114]	_	_
19-29	2003-2004	)	substance[109]|substance[110]|substance[114]	new[109]|new[110]|new[114]	_	_
19-30	2005-2012	protein	substance[109]|substance[110]|substance[114]	new[109]|new[110]|new[114]	_	_
19-31	2013-2014	.	_	_	_	_

#Text=However the other one , T. b. gambiense , was responsible for over 95 % of human deaths , and it had been previously unknown why .
20-1	2015-2022	However	_	_	_	_
20-2	2023-2026	the	person[115]	giv[115]	appos	20-6[116_115]
20-3	2027-2032	other	person[115]	giv[115]	_	_
20-4	2033-2036	one	person[115]	giv[115]	_	_
20-5	2037-2038	,	_	_	_	_
20-6	2039-2041	T.	person[116]	giv[116]	_	_
20-7	2042-2044	b.	person[116]	giv[116]	_	_
20-8	2045-2054	gambiense	person[116]	giv[116]	_	_
20-9	2055-2056	,	_	_	_	_
20-10	2057-2060	was	_	_	_	_
20-11	2061-2072	responsible	_	_	_	_
20-12	2073-2076	for	_	_	_	_
20-13	2077-2081	over	abstract[117]	new[117]	ana	20-21[0_117]
20-14	2082-2084	95	abstract[117]	new[117]	_	_
20-15	2085-2086	%	abstract[117]	new[117]	_	_
20-16	2087-2089	of	abstract[117]	new[117]	_	_
20-17	2090-2095	human	abstract[117]|event[118]	new[117]|giv[118]	_	_
20-18	2096-2102	deaths	abstract[117]|event[118]	new[117]|giv[118]	_	_
20-19	2103-2104	,	_	_	_	_
20-20	2105-2108	and	_	_	_	_
20-21	2109-2111	it	abstract	giv	_	_
20-22	2112-2115	had	_	_	_	_
20-23	2116-2120	been	_	_	_	_
20-24	2121-2131	previously	_	_	_	_
20-25	2132-2139	unknown	_	_	_	_
20-26	2140-2143	why	_	_	_	_
20-27	2144-2145	.	_	_	_	_

#Text=The study showed that a gene mutation has lead to a change in the parasite 's surface protein receptor .
21-1	2146-2149	The	abstract[120]	giv[120]	_	_
21-2	2150-2155	study	abstract[120]	giv[120]	_	_
21-3	2156-2162	showed	_	_	_	_
21-4	2163-2167	that	_	_	_	_
21-5	2168-2169	a	event[122]	new[122]	_	_
21-6	2170-2174	gene	abstract|event[122]	new|new[122]	_	_
21-7	2175-2183	mutation	event[122]	new[122]	_	_
21-8	2184-2187	has	_	_	_	_
21-9	2188-2192	lead	_	_	_	_
21-10	2193-2195	to	_	_	_	_
21-11	2196-2197	a	event[123]	new[123]	_	_
21-12	2198-2204	change	event[123]	new[123]	_	_
21-13	2205-2207	in	event[123]	new[123]	_	_
21-14	2208-2211	the	event[123]|abstract[127]	new[123]|new[127]	ana	22-1[0_127]
21-15	2212-2220	parasite	event[123]|person[124]|abstract[127]	new[123]|giv[124]|new[127]	coref	22-23[134_124]
21-16	2221-2223	's	event[123]|person[124]|abstract[127]	new[123]|giv[124]|new[127]	_	_
21-17	2224-2231	surface	event[123]|place|substance[126]|abstract[127]	new[123]|new|giv[126]|new[127]	_	_
21-18	2232-2239	protein	event[123]|substance[126]|abstract[127]	new[123]|giv[126]|new[127]	_	_
21-19	2240-2248	receptor	event[123]|abstract[127]	new[123]|new[127]	_	_
21-20	2249-2250	.	_	_	_	_

#Text=It does n't bind to TLF-1 as well as for other species , leading to a substantial decrease in TLF-1 uptake by the parasite .
22-1	2251-2253	It	abstract	giv	coref	23-1[135_0]
22-2	2254-2258	does	_	_	_	_
22-3	2259-2262	n't	_	_	_	_
22-4	2263-2267	bind	_	_	_	_
22-5	2268-2270	to	_	_	_	_
22-6	2271-2276	TLF-1	abstract	giv	coref	22-20
22-7	2277-2279	as	_	_	_	_
22-8	2280-2284	well	_	_	_	_
22-9	2285-2287	as	_	_	_	_
22-10	2288-2291	for	_	_	_	_
22-11	2292-2297	other	animal[130]	giv[130]	_	_
22-12	2298-2305	species	animal[130]	giv[130]	_	_
22-13	2306-2307	,	_	_	_	_
22-14	2308-2315	leading	_	_	_	_
22-15	2316-2318	to	_	_	_	_
22-16	2319-2320	a	event[131]	giv[131]	_	_
22-17	2321-2332	substantial	event[131]	giv[131]	_	_
22-18	2333-2341	decrease	event[131]	giv[131]	_	_
22-19	2342-2344	in	event[131]	giv[131]	_	_
22-20	2345-2350	TLF-1	event[131]|abstract|abstract[133]	giv[131]|giv|new[133]	coref	24-33
22-21	2351-2357	uptake	event[131]|abstract[133]	giv[131]|new[133]	_	_
22-22	2358-2360	by	event[131]|abstract[133]	giv[131]|new[133]	_	_
22-23	2361-2364	the	event[131]|abstract[133]|person[134]	giv[131]|new[133]|giv[134]	coref	23-20[139_134]
22-24	2365-2373	parasite	event[131]|abstract[133]|person[134]	giv[131]|new[133]|giv[134]	_	_
22-25	2374-2375	.	_	_	_	_

#Text=The receptor is more strict , causing a lower nutrient intake as well , but it suffices , and the parasite defends against the human immune system .
23-1	2376-2379	The	abstract[135]	giv[135]	_	_
23-2	2380-2388	receptor	abstract[135]	giv[135]	_	_
23-3	2389-2391	is	_	_	_	_
23-4	2392-2396	more	_	_	_	_
23-5	2397-2403	strict	_	_	_	_
23-6	2404-2405	,	_	_	_	_
23-7	2406-2413	causing	_	_	_	_
23-8	2414-2415	a	abstract[137]	new[137]	ana	23-16[0_137]
23-9	2416-2421	lower	abstract[137]	new[137]	_	_
23-10	2422-2430	nutrient	substance|abstract[137]	new|new[137]	coref	24-54[159_0]
23-11	2431-2437	intake	abstract[137]	new[137]	_	_
23-12	2438-2440	as	_	_	_	_
23-13	2441-2445	well	_	_	_	_
23-14	2446-2447	,	_	_	_	_
23-15	2448-2451	but	_	_	_	_
23-16	2452-2454	it	abstract	giv	_	_
23-17	2455-2463	suffices	_	_	_	_
23-18	2464-2465	,	_	_	_	_
23-19	2466-2469	and	_	_	_	_
23-20	2470-2473	the	person[139]	giv[139]	coref	24-44[156_139]
23-21	2474-2482	parasite	person[139]	giv[139]	_	_
23-22	2483-2490	defends	_	_	_	_
23-23	2491-2498	against	_	_	_	_
23-24	2499-2502	the	abstract[141]	giv[141]	coref	26-22[179_141]
23-25	2503-2508	human	abstract[141]	giv[141]	_	_
23-26	2509-2515	immune	organization|abstract[141]	giv|giv[141]	_	_
23-27	2516-2522	system	abstract[141]	giv[141]	_	_
23-28	2523-2524	.	_	_	_	_

#Text=As professor and head of the department of biochemistry and molecular biology at UGA ( and one of the leaders of the research ) Stephen Hajduk explained , " Humans have evolved TLF-1 as a highly specific toxin against African trypanosomes by tricking the parasite into taking up this HDL because it resembles a nutrient the parasite needs for survival .
24-1	2525-2527	As	_	_	_	_
24-2	2528-2537	professor	person	new	_	_
24-3	2538-2541	and	_	_	_	_
24-4	2542-2546	head	person[143]	new[143]	_	_
24-5	2547-2549	of	person[143]	new[143]	_	_
24-6	2550-2553	the	person[143]|organization[144]	new[143]|new[144]	_	_
24-7	2554-2564	department	person[143]|organization[144]	new[143]|new[144]	_	_
24-8	2565-2567	of	person[143]|organization[144]	new[143]|new[144]	_	_
24-9	2568-2580	biochemistry	person[143]|organization[144]|abstract	new[143]|new[144]|new	_	_
24-10	2581-2584	and	person[143]|organization[144]	new[143]|new[144]	_	_
24-11	2585-2594	molecular	person[143]|organization[144]|abstract[146]	new[143]|new[144]|new[146]	_	_
24-12	2595-2602	biology	person[143]|organization[144]|abstract[146]	new[143]|new[144]|new[146]	_	_
24-13	2603-2605	at	person[143]|organization[144]	new[143]|new[144]	_	_
24-14	2606-2609	UGA	person[143]|organization[144]|organization	new[143]|new[144]|new	_	_
24-15	2610-2611	(	_	_	_	_
24-16	2612-2615	and	_	_	_	_
24-17	2616-2619	one	person[148]	new[148]	_	_
24-18	2620-2622	of	person[148]	new[148]	_	_
24-19	2623-2626	the	person[148]|person[149]	new[148]|new[149]	_	_
24-20	2627-2634	leaders	person[148]|person[149]	new[148]|new[149]	_	_
24-21	2635-2637	of	person[148]|person[149]	new[148]|new[149]	_	_
24-22	2638-2641	the	person[148]|person[149]|abstract[150]	new[148]|new[149]|new[150]	coref	26-6[173_150]
24-23	2642-2650	research	person[148]|person[149]|abstract[150]	new[148]|new[149]|new[150]	_	_
24-24	2651-2652	)	_	_	_	_
24-25	2653-2660	Stephen	person[151]	new[151]	coref	27-1[180_151]
24-26	2661-2667	Hajduk	person[151]	new[151]	_	_
24-27	2668-2677	explained	_	_	_	_
24-28	2678-2679	,	_	_	_	_
24-29	2680-2681	"	_	_	_	_
24-30	2682-2688	Humans	animal	giv	coref	26-9
24-31	2689-2693	have	_	_	_	_
24-32	2694-2701	evolved	_	_	_	_
24-33	2702-2707	TLF-1	abstract	giv	coref	24-49[157_0]
24-34	2708-2710	as	_	_	_	_
24-35	2711-2712	a	substance[154]	new[154]	_	_
24-36	2713-2719	highly	substance[154]	new[154]	_	_
24-37	2720-2728	specific	substance[154]	new[154]	_	_
24-38	2729-2734	toxin	substance[154]	new[154]	_	_
24-39	2735-2742	against	substance[154]	new[154]	_	_
24-40	2743-2750	African	substance[154]|animal[155]	new[154]|new[155]	coref	28-5[190_155]
24-41	2751-2763	trypanosomes	substance[154]|animal[155]	new[154]|new[155]	_	_
24-42	2764-2766	by	_	_	_	_
24-43	2767-2775	tricking	_	_	_	_
24-44	2776-2779	the	person[156]	giv[156]	coref	24-56[160_156]
24-45	2780-2788	parasite	person[156]	giv[156]	_	_
24-46	2789-2793	into	_	_	_	_
24-47	2794-2800	taking	_	_	_	_
24-48	2801-2803	up	_	_	_	_
24-49	2804-2808	this	abstract[157]	giv[157]	ana	24-52[0_157]
24-50	2809-2812	HDL	abstract[157]	giv[157]	_	_
24-51	2813-2820	because	_	_	_	_
24-52	2821-2823	it	abstract	giv	coref	25-25
24-53	2824-2833	resembles	_	_	_	_
24-54	2834-2835	a	substance[159]	giv[159]	_	_
24-55	2836-2844	nutrient	substance[159]	giv[159]	_	_
24-56	2845-2848	the	substance[159]|person[160]	giv[159]|giv[160]	_	_
24-57	2849-2857	parasite	substance[159]|person[160]	giv[159]|giv[160]	_	_
24-58	2858-2863	needs	substance[159]	giv[159]	_	_
24-59	2864-2867	for	substance[159]	giv[159]	_	_
24-60	2868-2876	survival	substance[159]|event	giv[159]|new	_	_
24-61	2877-2878	.	_	_	_	_

#Text=But T. b. gambiense has evolved a counter measure to these human ' Trojan horses ' simply by barring the door and not allowing TLF-1 to enter the cell , effectively blocking human innate immunity and leading to infection and ultimately disease . "
25-1	2879-2882	But	_	_	_	_
25-2	2883-2885	T.	animal[162]|abstract[163]	giv[162]|new[163]	_	_
25-3	2886-2888	b.	animal[162]|abstract[163]	giv[162]|new[163]	_	_
25-4	2889-2898	gambiense	abstract[163]	new[163]	_	_
25-5	2899-2902	has	_	_	_	_
25-6	2903-2910	evolved	_	_	_	_
25-7	2911-2912	a	abstract[164]	new[164]	_	_
25-8	2913-2920	counter	abstract[164]	new[164]	_	_
25-9	2921-2928	measure	abstract[164]	new[164]	_	_
25-10	2929-2931	to	abstract[164]	new[164]	_	_
25-11	2932-2937	these	abstract[164]|animal[165]	new[164]|new[165]	_	_
25-12	2938-2943	human	abstract[164]|animal[165]	new[164]|new[165]	_	_
25-13	2944-2945	'	abstract[164]|animal[165]	new[164]|new[165]	_	_
25-14	2946-2952	Trojan	abstract[164]|animal[165]	new[164]|new[165]	_	_
25-15	2953-2959	horses	abstract[164]|animal[165]	new[164]|new[165]	_	_
25-16	2960-2961	'	abstract[164]|animal[165]	new[164]|new[165]	_	_
25-17	2962-2968	simply	_	_	_	_
25-18	2969-2971	by	_	_	_	_
25-19	2972-2979	barring	_	_	_	_
25-20	2980-2983	the	object[166]	new[166]	_	_
25-21	2984-2988	door	object[166]	new[166]	_	_
25-22	2989-2992	and	_	_	_	_
25-23	2993-2996	not	_	_	_	_
25-24	2997-3005	allowing	_	_	_	_
25-25	3006-3011	TLF-1	abstract	giv	_	_
25-26	3012-3014	to	_	_	_	_
25-27	3015-3020	enter	_	_	_	_
25-28	3021-3024	the	place[168]	new[168]	_	_
25-29	3025-3029	cell	place[168]	new[168]	_	_
25-30	3030-3031	,	_	_	_	_
25-31	3032-3043	effectively	_	_	_	_
25-32	3044-3052	blocking	_	_	_	_
25-33	3053-3058	human	abstract[169]	new[169]	_	_
25-34	3059-3065	innate	abstract[169]	new[169]	_	_
25-35	3066-3074	immunity	abstract[169]	new[169]	_	_
25-36	3075-3078	and	_	_	_	_
25-37	3079-3086	leading	_	_	_	_
25-38	3087-3089	to	_	_	_	_
25-39	3090-3099	infection	event	new	_	_
25-40	3100-3103	and	_	_	_	_
25-41	3104-3114	ultimately	abstract[171]	giv[171]	_	_
25-42	3115-3122	disease	abstract[171]	giv[171]	_	_
25-43	3123-3124	.	_	_	_	_
25-44	3125-3126	"	_	_	_	_

#Text=Based on the results of the research , humans could possibly develop a defense mechanism to keep the parasites from evading the human defense system .
26-1	3127-3132	Based	_	_	_	_
26-2	3133-3135	on	_	_	_	_
26-3	3136-3139	the	abstract[172]	new[172]	_	_
26-4	3140-3147	results	abstract[172]	new[172]	_	_
26-5	3148-3150	of	abstract[172]	new[172]	_	_
26-6	3151-3154	the	abstract[172]|abstract[173]	new[172]|giv[173]	coref	27-8[182_173]
26-7	3155-3163	research	abstract[172]|abstract[173]	new[172]|giv[173]	_	_
26-8	3164-3165	,	_	_	_	_
26-9	3166-3172	humans	animal	giv	_	_
26-10	3173-3178	could	_	_	_	_
26-11	3179-3187	possibly	_	_	_	_
26-12	3188-3195	develop	_	_	_	_
26-13	3196-3197	a	abstract[176]	new[176]	_	_
26-14	3198-3205	defense	abstract|abstract[176]	new|new[176]	coref	26-24
26-15	3206-3215	mechanism	abstract[176]	new[176]	_	_
26-16	3216-3218	to	abstract[176]	new[176]	_	_
26-17	3219-3223	keep	abstract[176]	new[176]	_	_
26-18	3224-3227	the	abstract[176]|animal[177]	new[176]|giv[177]	_	_
26-19	3228-3237	parasites	abstract[176]|animal[177]	new[176]|giv[177]	_	_
26-20	3238-3242	from	_	_	_	_
26-21	3243-3250	evading	_	_	_	_
26-22	3251-3254	the	abstract[179]	giv[179]	_	_
26-23	3255-3260	human	abstract[179]	giv[179]	_	_
26-24	3261-3268	defense	abstract|abstract[179]	giv|giv[179]	coref	27-25[188_0]
26-25	3269-3275	system	abstract[179]	giv[179]	_	_
26-26	3276-3277	.	_	_	_	_

#Text=Stephen Hajduk commented , " We believe this research represents a paradigm shift and causes us to think more broadly about how pathogens avoid host defense mechanisms .
27-1	3278-3285	Stephen	person[180]	giv[180]	_	_
27-2	3286-3292	Hajduk	person[180]	giv[180]	_	_
27-3	3293-3302	commented	_	_	_	_
27-4	3303-3304	,	_	_	_	_
27-5	3305-3306	"	_	_	_	_
27-6	3307-3309	We	person	acc	ana	27-16
27-7	3310-3317	believe	_	_	_	_
27-8	3318-3322	this	abstract[182]	giv[182]	_	_
27-9	3323-3331	research	abstract[182]	giv[182]	_	_
27-10	3332-3342	represents	_	_	_	_
27-11	3343-3344	a	event[184]	new[184]	_	_
27-12	3345-3353	paradigm	abstract|event[184]	new|new[184]	_	_
27-13	3354-3359	shift	event[184]	new[184]	_	_
27-14	3360-3363	and	_	_	_	_
27-15	3364-3370	causes	_	_	_	_
27-16	3371-3373	us	person	giv	_	_
27-17	3374-3376	to	_	_	_	_
27-18	3377-3382	think	_	_	_	_
27-19	3383-3387	more	_	_	_	_
27-20	3388-3395	broadly	_	_	_	_
27-21	3396-3401	about	_	_	_	_
27-22	3402-3405	how	_	_	_	_
27-23	3406-3415	pathogens	substance	new	_	_
27-24	3416-3421	avoid	_	_	_	_
27-25	3422-3426	host	person|abstract[188]|abstract[189]	new|giv[188]|new[189]	_	_
27-26	3427-3434	defense	abstract[188]|abstract[189]	giv[188]|new[189]	_	_
27-27	3435-3445	mechanisms	abstract[189]	new[189]	_	_
27-28	3446-3447	.	_	_	_	_

#Text=It turns out that African trypanosomes have evolved a diversity of ways to avoid human innate and acquired immune systems . "
28-1	3448-3450	It	_	_	_	_
28-2	3451-3456	turns	_	_	_	_
28-3	3457-3460	out	_	_	_	_
28-4	3461-3465	that	_	_	_	_
28-5	3466-3473	African	animal[190]	giv[190]	_	_
28-6	3474-3486	trypanosomes	animal[190]	giv[190]	_	_
28-7	3487-3491	have	_	_	_	_
28-8	3492-3499	evolved	_	_	_	_
28-9	3500-3501	a	abstract[191]	new[191]	_	_
28-10	3502-3511	diversity	abstract[191]	new[191]	_	_
28-11	3512-3514	of	abstract[191]	new[191]	_	_
28-12	3515-3519	ways	abstract[191]|abstract	new[191]|new	_	_
28-13	3520-3522	to	_	_	_	_
28-14	3523-3528	avoid	_	_	_	_
28-15	3529-3534	human	abstract[193]	new[193]	_	_
28-16	3535-3541	innate	abstract[193]	new[193]	_	_
28-17	3542-3545	and	abstract[193]	new[193]	_	_
28-18	3546-3554	acquired	abstract[193]	new[193]	_	_
28-19	3555-3561	immune	abstract[193]	new[193]	_	_
28-20	3562-3569	systems	abstract[193]	new[193]	_	_
28-21	3570-3571	.	_	_	_	_
28-22	3572-3573	"	_	_	_	_
